Clinical Trials Browser

Bulbo-Spinal Atrophy, X-Linked × darolutamide × 1 year × Clear all

NCT07190300 2026-03-02

TulmiSTAR-02

Phase 1/2 Recruiting

Bulbo-Spinal Atrophy, X-Linked

NCT05694819 2025-05-22

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Phase 2 Active not recruiting

Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked